Clinical Trials Browser

Terminated × Interventional × Immunoglobulins × Clear all

NCT04438382 2026-02-27

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Phase 2 Terminated

1 enrolled 1 chart

Other hematologic neoplasm

Hematologic Neoplasms

NCT00004682 2015-03-25

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Phase NA Terminated

Mental Disorders, Myasthenia Gravis, Neurologic Manifestations, Rare Diseases